Radial Shock Waves (rESWT) for Pain

What r-ESWT Is

Radial shock wave therapy — designated by the acronym r-ESWT (radial Extracorporeal Shock Wave Therapy) — uses pneumatic pressure waves generated when a metal projectile accelerated by compressed air impacts the rear of the applicator. The kinetic energy of the impact converts into an acoustic wave that propagates in a divergent and dispersive manner in a cone from the applicator head — and not focused at a deep point.

In terms of application physics, this difference is foundational. r-ESWT has maximum energy at the surface and undergoes progressive attenuation as the wave advances into tissue, with effective depth of 3 to 4 cm. Dose is expressed in bar (pneumatic pressure unit), typically in the range of 1 to 5 bar, different from the energy flux density in mJ/mm² used in the focal modality. Applicator heads with distinct diameters (15 mm for more superficial targets, 20-25 mm for slightly thicker tissues within the penetration limit) modulate impact distribution.

It is important to clearly distinguish r-ESWT from focal shock waves (f-ESWT). Shock-wave technology was originally developed for renal lithotripsy in the 1980s and, later, adapted for musculoskeletal applications in two distinct strands. The focal modality concentrates energy in a small, deep target zone; the radial disperses pneumatic pressure superficially over a wide area. The two are complementary tools, not interchangeable: each responds well to a particular anatomic profile and to specific indications, as detailed later in the comparative table of this article.

Mechanism of Action

The mechanism of r-ESWT is predominantly mechanical-superficial, with biological effect distributed in layers 0 to 3 cm in depth. The pneumatic pressure wave, on crossing dermis, subcutaneous tissue, and fascia, produces tissue mechanotransduction stimulus — the conversion of mechanical energy into cellular signals that modulate fibroblast activity, muscle fibers, and perineural structures. Unlike f-ESWT, in which deep energy concentration produces cavitation and localized microtrauma, in r-ESWT energy is distributed over a broad area and in a superficial plane, which results in less point tissue disruption.

In myofascial pain, the most relevant clinical effect appears to be modulation of trigger points by percutaneous mechanical action on palpable taut bands. Broad area coverage — a single session may address upper trapezius, scalenes, levator scapulae, and infraspinatus in the same application — is a real operational advantage in regional myofascial syndrome. The mechanistic hypothesis invokes components of segmental gate control, modulation of local nociceptors, and possible release of myofascial mediators (substance P, bradykinin) during mechanical disorganization of the taut band.

A third less-studied front is the release of tissue growth factors — VEGF, TGF-β — described in preclinical studies after radial application, with magnitude generally inferior to that documented in f-ESWT. In superficial tendinopathies (lateral epicondylitis, plantar fasciitis at the insertion), this regenerative cascade contributes to part of the observed effect, although the translational evidence for r-ESWT is less robust than for focal. The overall model can be summarized this way: distributed superficial mechanotransduction + local gate control + regenerative contribution of lower intensity. The clinical translation is moderate effect in superficial conditions and inadequate effect in deep conditions.

Evidence by Condition

r-ESWT evidence has contours distinct from f-ESWT and requires equally condition-specific reading. In general, the literature accumulates reasonable support for superficial applications — regional myofascial pain, chronic plantar fasciitis, epicondylitis — and limited support for conditions in which target depth exceeds the physical limit of the technology. This reading is important: speaking of "shock waves working" without qualifying focal vs radial and without naming the condition is simplification that distorts clinical decision.

In myofascial pain and trigger points, the systematic review by Eickmeyer et al. synthesized moderate-quality RCTs examining r-ESWT applied over taut bands of trapezius, levator scapulae, and other superficial groups. The pattern is one of modest-to-moderate benefit on pain and pressure threshold at trigger points, with effect that usually consolidates over 3 to 6 weekly sessions. The literature is heterogeneous regarding standardization of protocols (pressure, pulses, number of sessions), but the direction of effect is consistent across studies comparing with inactive control.

In chronic plantar fasciitis, r-ESWT meta-analyses generally find modest-to-moderate benefit on morning pain and function, with effect size somewhat inferior to the focal modality in indirect comparative analyses, but clinically relevant. In Achilles tendinopathy, specific trials with r-ESWT (e.g., Rompe, Notarnicola) showed favorable results compared with conservative therapy in chronic conditions. Note: the trial by Cacchio (2009, JBJS-A), frequently cited, used focal ESWT, not radial. Worth remembering: for Achilles, structured eccentric exercise (Alfredson program) remains first line, and r-ESWT plays an adjunctive role.

In chronic lateral epicondylitis, evidence supports moderate benefit in conditions > 3-6 months refractory to physical therapy, with response profile comparable to that documented in f-ESWT in the same condition — coherent with the superficial depth of the epicondyle. In calcific tendinopathy of the shoulder, by contrast, evidence for r-ESWT is less robust than for f-ESWT: the hydroxyapatite deposit is in deep plane in the critical zone of the supraspinatus, and radial energy attenuates before reaching the target with the intensity needed for mechanical fragmentation and regenerative stimulus. Modality choice in this particular indication favors focal.

In deep pathologies — trochanteric bursitis, deep gluteal pain, gluteal enthesopathies, pseudarthrosis of long bones — r-ESWT has insufficient or absent evidence, and the physics of the technology explains this gap: target depth exceeds the 3-4 cm limit. Radial applications in these conditions tend to produce results inferior to those documented with f-ESWT. The resulting practical guidance is clear: for deep conditions, f-ESWT is the choice; r-ESWT should not even be considered as an equivalent alternative.

r-ESWT vs f-ESWT — comparative table

This table is the technical core of the article. The choice between radial and focal shock waves is not clinical preference — it is an anatomic and condition-specific decision. The items below summarize the differences that matter in practice.

Indications

r-ESWT indications follow two axes: superficial target depth (target within the 3-4 cm limit) and chronicity with failure of initial conservative treatment. None of the indications below is first-line; r-ESWT occupies a second-line position in most scenarios, after attempting modalities with better primary evidence per condition (prescribed exercise, structured physical therapy, pertinent pharmacologic management).

How It Is Performed and What to Expect

The r-ESWT session takes place in a medical office or rehabilitation center, with the patient positioned to expose the region to be treated. After palpation and mapping of trigger points or the symptomatic area, ultrasonographic coupling gel is applied (for adequate transmission of the pneumatic wave) and the applicator head is positioned on the skin with moderate pressure. The operator displaces the applicator in overlapping paths over the target area, allowing homogeneous coverage.

Typical parameters vary according to condition and tissue: 2000 to 4000 pulses per session, pressure between 2 and 3 bar (adjusted to patient tolerance), trigger frequency of 10 to 15 Hz. The applicator head chosen depends on target tissue: 15 mm for superficial tissues (plantar fascia, epicondyle), 25 mm for slightly thicker tissues within the 3-4 cm limit. A relevant operational feature of r-ESWT is the considerably lower discomfort than that of f-ESWT, which allows application without routine local anesthesia and better tolerability in patients with greater sensitivity.

Each session lasts on average 10 to 20 minutes, with a typical protocol of 3 to 6 weekly sessions, followed by clinical reassessment between 4 and 8 weeks after the last. Because the magnitude of biological response of r-ESWT is inferior to that of f-ESWT, the consolidation window may be slightly shorter — but premature judgment (at the 1st or 2nd session) is as inadequate as in the focal modality.

An essential operational point, identical to f-ESWT: r-ESWT does not replace rehabilitation. The best results occur when the technique is a component of a program including condition-specific exercise (eccentric for tendinopathies, specific stretching and load reeducation for plantar fasciitis, postural correction and strengthening in cervicobrachial myofascial syndrome). Applied in isolation, r-ESWT tends to produce transient symptomatic relief with recurrence after the series.

Adverse Effects, Risks, and Contraindications

r-ESWT presents a favorable safety profile and, in terms of adverse effects, less severe than those of f-ESWT — superficial energy distribution reduces both pain during application and the frequency of post-application reactions. Even so, there are rigorous absolute contraindications and situations requiring caution; the technique is not free of risk.

Attention to the acute reactive phase: although r-ESWT delivers less point energy than focal, application over acute reactive tendinopathy (< 6 weeks) can worsen an active inflammatory condition. The rule is analogous to f-ESWT: wait for transition to chronic phase before considering the technique, regardless of modality. Pregnancy and open epiphyses: pregnancy is an absolute contraindication in any trimester on a precautionary principle; in children and adolescents, applications over growth cartilage are formally contraindicated, and any applications in other regions should be evaluated by a specialist with pediatric experience.

Limitations and What Is Still Not Known

r-ESWT has relevant methodologic and practical gaps. Most stem from clinical confusion between modalities — by far the most common I observe in consultation — and from protocol heterogeneity. The section below summarizes the main ones.

Central Gaps

Non-standardized protocols across manufacturers. Pressure in bar, pulses per session, total number of sessions, and intervals vary significantly across radial equipment on the market. This heterogeneity limits direct transferability of published results and hampers robust meta-analyses outside tightly defined indications. An honest reading of an r-ESWT study requires noting equipment, parameters, and manufacturer.

Direct f-ESWT vs r-ESWT RCTs are scarce. Despite broad clinical use of both, head-to-head comparison in specific conditions is limited. The choice between the two modalities tends to rest on theoretical considerations (target depth, center availability) rather than on direct, high-quality comparative evidence. This does not invalidate rational choice based on physical features, but it limits the strength of comparative recommendations.

Role in mixed chronic pain little studied. Real-world conditions frequently combine a regional myofascial component, multiple trigger points, biomechanical alteration, and central sensitization. RCTs with isolated diagnoses do not capture this scenario, and r-ESWT performance in mixed syndromes remains an open question. Clinical experience suggests benefit on the myofascial component, with relatively limited effect on central or deep components.

Cost and access. r-ESWT equipment is more accessible than focal, which broadens supply in many markets, especially in physical therapy, sports medicine, and musculoskeletal medicine clinics. In public health systems, availability is typically limited. In private insurance, coverage varies by operator. In private practice, per-session cost is usually moderate. Greater r-ESWT supply relative to focal, however, should not be interpreted as clinical equivalence — it is merely an operational factor.

Relationship with Medical Acupuncture

r-ESWT and medical acupuncture share a partial biological platform: both modulate myofascial trigger points and both have a component of local mechanical/neural stimulus. Acupuncture acts predominantly through neuromodulatory pathway (activation of Aδ and C fibers, gate control, release of endogenous opioids, modulation of the descending inhibitory pathway); r-ESWT acts via superficial mechanical pathway with secondary neuromodulatory contribution. Mechanisms are overlapping but not identical — and this overlap opens the possibility of sequential use in regional myofascial syndromes.

In practice, a frequent arrangement is r-ESWT as mechanical preparation — disorganization of taut bands, initial reduction of myofascial hypertonia, modulation of extensive trigger points — followed by acupuncture for neuromodulation at key points and areas of persistent referred pain. The sequence tends to be better tolerated than simultaneous application on the same day, with typical interval of 24-48 hours between modalities in the same region. In specific contexts, there is literature on combining shock waves with dry needling — see our dedicated article on the shock waves + dry needling combination for technical details of this protocol.

When to Seek Medical Help

The decision to evaluate r-ESWT begins with a structured medical consultation that includes diagnostic characterization of pain and review of treatments already tried. Seeking the technique without a clear indication — or for conditions whose target depth exceeds the technology's limit — tends to produce clinical frustration. Reading the indication correctly is, alongside operator experience, the greatest determinant of outcome.